Similar articles

• Human pharmacology and clinical evaluation of an oral carbenicillin preparation.

  Bran JL, Karl DM, Kaye D. Bran JL, et al. Clin Pharmacol Ther. 1971 May-Jun;12(3):525-30. doi: 10.1002/cpt1971123525. Clin Pharmacol Ther. 1971. PMID: 5208911 No abstract available.
• A clinical investigation of pivmecillinam. A novel beta-lactam antibiotic in the treatment of urinary tract infections.

  Wise R, Reeves DS, Symonds JM, Wilkinson PJ. Wise R, et al. Chemotherapy. 1976;22(5):335-9. doi: 10.1159/000221942. Chemotherapy. 1976. PMID: 181216
• Carbenicillin, clinicolaboratory experience.

  Daïkos GD, Kontomichalou P, Zerefos N, Caralampidou A, Papachristou E. Daïkos GD, et al. Chemotherapy. 1970;15(1):45-51. doi: 10.1159/000220664. Chemotherapy. 1970. PMID: 4985486 No abstract available.
• Mecillinam resistance in clinical practice--a review.

  Anderson JD. Anderson JD. J Antimicrob Chemother. 1977 Jul;3 Suppl B:89-96. doi: 10.1093/jac/3.suppl_b.89. J Antimicrob Chemother. 1977. PMID: 330485 Review. No abstract available.
• Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections.

  Concia E, Bragantini D, Mazzaferri F. Concia E, et al. J Chemother. 2017 Dec;29(sup1):19-28. doi: 10.1080/1120009X.2017.1380397. J Chemother. 2017. PMID: 29271735 Review.